These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7862909)

  • 1. PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo.
    Nybäck H; Halldin C; Ahlin A; Curvall M; Eriksson L
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):31-6. PubMed ID: 7862909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo.
    Nordberg A; Hartvig P; Lundqvist H; Antoni G; Ulin J; Långström B
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):195-205. PubMed ID: 2789067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of (S)-N-[methyl-11C]nicotine and its regional distribution in the mouse brain: a potential tracer for visualization of brain nicotinic receptors by positron emission tomography.
    Saji H; Magata Y; Yamada Y; Tajima K; Yonekura Y; Konishi J; Ohmomo Y; Yokoyama A
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):734-6. PubMed ID: 1611685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An attempt to visualize baboon brain nicotinic receptors with N-[11C]ABT-418 and N-[11C]methyl-cytisine.
    Valette H; Bottlaender M; Dollé F; Dolci L; Syrota A; Crouzel C
    Nucl Med Commun; 1997 Feb; 18(2):164-8. PubMed ID: 9076773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys.
    Sihver W; Fasth KJ; Ogren M; Lundqvist H; Bergström M; Watanabe Y; Långström B; Nordberg A
    Nucl Med Biol; 1999 Aug; 26(6):633-40. PubMed ID: 10587101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.
    Nordberg A; Lundqvist H; Hartvig P; Lilja A; Långström B
    Alzheimer Dis Assoc Disord; 1995; 9(1):21-7. PubMed ID: 7605618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (S)-(-)-[11C]nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain.
    Lundqvist H; Nordberg A; Hartvig P; Långström B
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):238-46. PubMed ID: 9772029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET.
    Halldin C; Någren K; Swahn CG; Långström B; Nybäck H
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):871-80. PubMed ID: 1428915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies.
    Sihver W; Fasth KJ; Ogren M; Bivehed H; Bergström M; Nordberg A; Watanabe Y; Långström B
    J Neurochem; 1998 Oct; 71(4):1750-60. PubMed ID: 9751211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET quantification of specific binding of carbon-11-nicotine in human brain.
    Muzic RF; Berridge MS; Friedland RP; Zhu N; Nelson AD
    J Nucl Med; 1998 Dec; 39(12):2048-54. PubMed ID: 9867140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies.
    Pomper MG; Musachio JL; Scheffel U; Macdonald JE; McCarthy DJ; Reif DW; Villemagne VL; Yokoi F; Dannals RF; Wong DF
    J Nucl Med; 2000 Aug; 41(8):1417-25. PubMed ID: 10945536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.
    Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P
    Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography.
    Nordberg A; Hartvig P; Lilja A; Viitanen M; Amberla K; Lundqvist H; Andersson Y; Ulin J; Winblad B; Långström B
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):215-24. PubMed ID: 2257061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.
    Kadir A; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2006 Nov; 188(4):509-20. PubMed ID: 16832659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of carbon-11 labelled nicotine in the measurement of human cerebral blood flow and other physiological parameters.
    Yokoi F; Komiyama T; Ito T; Hayashi T; Lio M; Hara T
    Eur J Nucl Med; 1993 Jan; 20(1):46-52. PubMed ID: 8420783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.
    Iida Y; Ogawa M; Ueda M; Tominaga A; Kawashima H; Magata Y; Nishiyama S; Tsukada H; Mukai T; Saji H
    J Nucl Med; 2004 May; 45(5):878-84. PubMed ID: 15136639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of 11C-(R)nicotine in human brain measured by positron emission tomography: measurement of cerebral blood flow.
    Hara T; Komiyama T; Yokoi F
    Yakubutsu Seishin Kodo; 1993 Jun; 13(3):175-81. PubMed ID: 8237133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
    Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
    Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of radioiodinated (S)-5-iodonicotine: a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography.
    Saji H; Watanabe A; Magata Y; Ohmomo Y; Kiyono Y; Yamada Y; Iida Y; Yonekura Y; Konishi J; Yokoyama A
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):284-90. PubMed ID: 9118442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.